NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 79 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q2 2015. The put-call ratio across all filers is 110.59 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $154,000 | -59.2% | 244,395 | -40.7% | 0.00% | -100.0% |
| Q3 2016 | $377,000 | +45.0% | 412,210 | -15.9% | 0.00% | – |
| Q2 2016 | $260,000 | +36.1% | 489,990 | +142.3% | 0.00% | – |
| Q1 2016 | $191,000 | +38.4% | 202,241 | +95.5% | 0.00% | – |
| Q4 2015 | $138,000 | +228.6% | 103,444 | +293.9% | 0.00% | – |
| Q2 2015 | $42,000 | -28.8% | 26,263 | -16.0% | 0.00% | – |
| Q4 2014 | $59,000 | +268.8% | 31,282 | +183.2% | 0.00% | – |
| Q2 2014 | $16,000 | -77.5% | 11,045 | -58.5% | 0.00% | – |
| Q3 2013 | $71,000 | – | 26,619 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Platinum Management (NY) LLC | 10,375,329 | $13,549,000 | 19.76% |
| Catalyst Capital Advisors LLC | 790,000 | $1,635,000 | 0.53% |
| DSC Advisors, L.P. | 500,000 | $1,035,000 | 0.50% |
| STONERIDGE INVESTMENT PARTNERS LLC | 142,528 | $295,000 | 0.06% |
| Hudock, Inc. | 30,500 | $63,000 | 0.05% |
| BRR OpCo, LLC | 52,700 | $109,000 | 0.05% |
| TFS CAPITAL LLC | 418,074 | $865,000 | 0.04% |
| LifePlan Financial Group, Inc | 28,810 | $60,000 | 0.04% |
| NOMURA HOLDINGS INC | 3,831,177 | $7,947,000 | 0.04% |
| BOLTON LP | 77,400 | $160,000 | 0.03% |